Literature DB >> 15880325

Pathology of thin basement membrane nephropathy.

Kirk Foster1, Glen S Markowitz, Vivette D D'Agati.   

Abstract

Thin basement membrane nephropathy (TBMN) is a glomerular disorder characterized clinically by isolated hematuria and pathologically by diffuse thinning of the glomerular basement membrane (GBM) on ultrastructural examination. The pathologic diagnosis of TBMN is problematic, in part because of the wide range of GBM thicknesses in the normal population. GBM thickness varies with age, sex, and the different methods of tissue preparation and measurement. In addition, there are no standardized diagnostic criteria defining the degree or extent of GBM thinning required for the diagnosis of TBMN. GBM thinning is often seen in other glomerulopathies, where it may represent an overlap with TBMN or may be secondary to GBM damage and remodeling. Importantly, TBMN must be differentiated from the GBM thinning seen in some renal biopsy specimens from boys and female heterozygotes with X-linked Alport syndrome because of the very different prognoses of these two conditions.

Entities:  

Mesh:

Year:  2005        PMID: 15880325     DOI: 10.1016/j.semnephrol.2005.01.006

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  5 in total

1.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

2.  Pathologic glomerular characteristics and glomerular basement membrane alterations in biopsy-proven thin basement membrane nephropathy.

Authors:  Yusuke Kajimoto; Yoko Endo; Mika Terasaki; Shinobu Kunugi; Toru Igarashi; Akiko Mii; Yasuhiro Terasaki; Akira Shimizu
Journal:  Clin Exp Nephrol       Date:  2019-01-28       Impact factor: 2.801

3.  Co-existence of thin basement membrane nephropathy with other glomerular pathologies; a single center experience.

Authors:  Rizwan A Qazi; Bahar Bastani
Journal:  J Nephropathol       Date:  2015-04-01

4.  Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome.

Authors:  Samar M Said; Mary E Fidler; Anthony M Valeri; Brooke McCann; Wade Fiedler; Lynn D Cornell; Mariam Priya Alexander; Ahmed M Alkhunaizi; Anne Sullivan; Carl H Cramer; Marie C Hogan; Samih H Nasr
Journal:  Kidney Int Rep       Date:  2016-09-29

5.  Minimal change disease with concurrent thin basement membrane disease: A case report.

Authors:  Abdulaziz I Alroshodi
Journal:  Int J Health Sci (Qassim)       Date:  2020 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.